Related Experiment Video
Updated: Oct 16, 2025
04:59
Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation
Published on: January 19, 2024
2.7K
The "heart brain" and neuromodulation for vasovagal syncope
Tolga Aksu1, Andre Davila2, Dhiraj Gupta3
1Yeditepe University Hospital, Department of Cardiology, Istanbul, Turkey.
Autonomic Neuroscience : Basic & Clinical
|October 19, 2021
Summary
The autonomic nervous system (ANS) plays a key role in vasovagal syncope (VVS). Catheter-based neuromodulation (CNA) of the cardiac ANS is now a common procedure, offering a new treatment approach.
Area of Science:
- Cardiology
- Neuroscience
- Anatomy
Background:
- The autonomic nervous system (ANS) is implicated in the development of vasovagal syncope (VVS).
- Catheter-based neuromodulation (CNA) targeting the intrinsic cardiac ANS has transitioned from experimental to clinical practice.
- This procedure is increasingly performed in major medical centers globally.
Purpose of the Study:
- To consolidate anatomical knowledge of the intrinsic cardiac ANS.
- To review clinical data on intrinsic cardiac neuromodulation.
- To offer practical guidance for electrophysiologists.
Main Methods:
- Review of anatomical terminologies related to the intrinsic cardiac ANS.
- Analysis of existing clinical data on cardiac neuromodulation procedures.
- Synthesis of anatomical and clinical information.
Main Results:
- The intrinsic cardiac ANS comprises specific anatomical structures crucial for its function.
- Clinical data demonstrate the evolving efficacy and safety of CNA for VVS.
- The review provides a unified perspective on the anatomy and clinical applications of CNA.
Conclusions:
- Understanding the intrinsic cardiac ANS anatomy is vital for effective neuromodulation.
- CNA represents a significant advancement in managing VVS.
- This review serves as a practical resource for electrophysiology professionals.
Keywords:
Autonomic nervous systemBradycardiaCardioneuroablationGanglionated plexusParasympatheticVagal nerveMore Related Videos
Related Concept Videos
01:29Heart Failure II: Pathophysiology
102
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
102
01:18Neural Regulation of Blood Pressure
5.3K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
5.3K
01:30Heart Failure V: Medical Management
51
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
51
01:22Heart Failure Drugs: β-Blockers
485
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
485
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
572
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
572
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
114
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
114